Contact us

Thank you for your interest in Garg Law PLLC.

Our commitment to understanding your regulatory questions and business goals, and helping you achieve results starts here.

If you are looking for representation on a new matter, please fill out the form below to request a free consultation. The form enables us to conduct a preliminary check for potential conflicts of interest and to determine if we can proceed with the free consultation.

FDA Medical Device Registration Lawyer for Miami

Miami is the principal port of entry for the southeastern United States — PortMiami and Miami International Airport together move a huge share of the country’s waterborne and air cargo, and the businesses that import, distribute and market FDA-regulated products across the Americas run their operations from here. More FDA-regulated freight crosses this city than almost any other American market. That concentration of regulated commerce is why Garg Law brings its FDA and customs practice to Miami businesses from a Miami office on Brickell Avenue — close enough to the port, the airport and the agencies to act the day a problem surfaces. Whether the issue is a detained container at PortMiami, a labeling question before a product launch, or a registration deadline, Miami companies need FDA counsel that works at the port’s pace.

Understanding device registration matters

Medical device establishment registration renews every year in the October 1 – December 31 window, with an annual user fee that must clear before registration completes. Alongside it sits device listing: every device an establishment manufactures, develops, relabels or imports must be listed under the correct regulation number and product code, and updated as the portfolio changes.

The obligations map by role: foreign manufacturers register with a U.S. agent; initial importers — the first U.S. establishments taking distribution — register too, a fact that surprises Miami trading companies regularly. Relabelers, repackagers and specification developers all carry their own registration and listing duties.

Entry screening makes it operational: device entries carry affirmations of compliance citing registration and listing numbers, and FDA’s systems verify them at the border. A lapsed registration, an unpaid fee or an unlisted model shows up as a hold on a shipment hospitals and distributors are waiting for — Miami’s device corridor sees it weekly.

Acting early vs. waiting: what it costs

Registration gaps are binary at the border — the entry either verifies or it holds. For device distributors the collateral damage is contractual: hospital and clinic supply commitments do not pause for a lapsed renewal, and a competitor with clean records takes the standing order you could not fill.

The engagement, step by step

  1. Role analysis across your operation — manufacturer, importer, relabeler — and the registration architecture each requires
  2. Annual registration and user-fee management with the renewal-window discipline FDA enforces
  3. Device listing build-out and maintenance: correct product codes, complete models, timely updates
  4. U.S. agent arrangements for foreign establishments in your supply chain
  5. Border-issue response: diagnosing registration-based holds and correcting the records that caused them

Five mistakes that sink these matters

  • Missing the annual renewal window or letting the user fee payment fail silently
  • Importing as an unregistered initial importer — the role registers, not just the factory
  • Listing gaps: new models and relabeled versions never added under the right product codes
  • Foreign supplier registrations naming defunct U.S. agents
  • Entry affirmations that do not match FDA’s records exactly — near-matches hold too

FDA Medical Device Registration Lawyer services for Miami

The work around Miami — international trade companies, food and beverage importers, cosmetics and consumer brands, medical and pharmaceutical distributors, logistics and freight networks — is FDA-regulated at nearly every turn, and matters here move on the gateway city — PortMiami, Miami International Airport and the headquarters of hemispheric trade. Garg Law's Miami office is at 1221 Brickell Avenue, and the practice was built for exactly this market: founder Shelly Garg spent years counseling importers at the world's largest dedicated international trade law firm before opening her own, and works at the crossroads of FDA and CBP compliance for foreign and domestic companies across the food, beverage, supplement, cosmetics, OTC drug and medical device industries.

Frequently asked questions

Who has to register as a device establishment?

Manufacturers, contract manufacturers and sterilizers, specification developers, repackagers, relabelers and initial importers — foreign and domestic. If your company takes first U.S. distribution of an imported device, you are an initial importer and must register, regardless of who made it.

When does device registration renew and what does it cost?

Annually, October 1 through December 31, with the establishment user fee paid as part of renewal. Miss the window or the payment and the registration lapses — and lapsed registration status is exactly what the import screen checks.

What is device listing and how is it different from registration?

Registration identifies the establishment; listing identifies the devices — each under its regulation number and product code. Both must be current: a registered importer shipping an unlisted model still fails entry verification. Listings need maintenance as products, models and labels evolve.

Do foreign device makers need anything besides registration?

A U.S. agent for FDA communications, complete listings, and compliance with premarket requirements for everything shipped. Importers should verify all of it upstream — the border consequences of a foreign supplier’s gaps land on the U.S. importer’s dock.

Our device shipment was held for a registration mismatch — now what?

Pull the entry’s affirmations and compare them against FDA’s establishment and listing databases: wrong numbers, lapsed renewals and unlisted models are the usual suspects. Correct the actual record, resubmit through your broker, and follow up with the reviewing FDA office — quickly, before storage charges eat the shipment.

Related services

Request a Consultation

★★★★★

Working with Shelly on various new product launches over the last couple of years has been seamless. Quick and clear guidance is always what we get.
R.G. Client
I've been working with Shelly and her team at Garg law for a little while now and they are fantastic! Very responsive, professional and they certainly get things done. Extremely satisfied with their service and highly recommend.
Mike H. Client
Ms Garg helped my company navigate an FDA import issue. She achieved an excellent result, was very responsive and professional, and managed to keep the project within budget. She is a stellar attorney.
Dr. Sastry Client
I have been using Shelly Garg as FDA Counsel for 10+ years, since she was at another international law firm. While we continued to use the previous firm she was at (mainly due to the process required to change firms), we realized the quality of counsel was not the same. We have since been using Garg Law and the ease of use and trust in the knowledge was back instantly. Shelly has the skills to help me understand the regulations (by translating into layman's terms) and risks in a manner that is specific to my business. She is also extremely timely in her responses which is critical when we have a deadline mandated by the FDA. Many other attorneys cite the regulations which l've already read, but need further counsel. In my opinion, this demonstrates Shelly's in-depth knowledge of the regulations, how they pertain to the law, and how they are applicable IRL. Shelly's personable approach and pleasant manner in communication makes it very easy to have been work with her and have productive discussions on the best next steps. She truly has a passion iternational for all things FDA and I've learned so much from her.
Claire P. Client

News & Insights

Get the latest news on FDA regulatory delivered straight to your inbox.